PPAP is best treated as a buyer–supplier decision package, not a stack of forms. AIAG describes the Production Part Approval Process as the industry standard for showing that engineering design-record and specification requirements can be met consistently during an actual production run at production rates [1]. The request should not assume that every programme needs the same documentation. A first article injection molding review can be a useful early checkpoint, but its name alone does not determine whether it is a PPAP submission or what evidence a customer expects.
A disciplined submission prevents two opposite errors: collecting documents that cannot support an acceptance decision, or approving parts while assumptions remain hidden. The product owner should retain authority over functional requirements and acceptance, while the molder explains how the proposed production route and records relate to those requirements. AIAG’s current APQP material explicitly addresses sourcing, change management, risk-assessment mitigation and gated management [2]. Those topics make a practical frame for a submission plan even where a customer does not prescribe an automotive-style PPAP. The depth remains part-specific: an internal non-cosmetic cover, a safety-relevant interface and a visible part with a mating assembly do not present the same risks.
PPAP evidence supports a decision on a defined part and production baseline; it does not replace the buyer’s controlled product requirements [1].
01
Set the decision and release boundary before evidence begins
Start by writing the decision that the submission is meant to support. It may be permission to build pilot assemblies, conditional release pending a named open point, or release to routine purchasing. Then lock the baseline: part number, drawing and CAD revision, approved material direction, tooling and cavity identity where relevant, colour or appearance reference, and packaging requirement. The submission request should also identify whether the run is expected to represent the intended production route or whether it is an exploratory trial. Without that distinction, a measurement result can be technically correct yet answer the wrong business question.
Assign ownership alongside the boundary. The buyer or product owner normally supplies the controlled design record, identifies critical interfaces and decides which deviations are acceptable. The molder normally prepares agreed production and inspection evidence, identifies assumptions and proposes containment where an issue is found. Quality, engineering and procurement should agree who may accept a deviation, who can release a revision and who receives the final decision. AIAG positions PPAP around meeting design-record and specification requirements consistently in an actual production context [1].
02
Choose evidence by the decision it must support
Do not begin by requesting a generic ‘full package.’ Instead, connect each item to a buyer decision. A controlled design record and marked characteristics can establish what is being judged. A process flow and control plan can explain where a relevant characteristic is created, checked and reacted to. AIAG’s Control Plan guidance describes linkages to APQP and guidance on developing and using control plans [3]. Risk analysis, capability or other study results, material records, appearance references and sample results can each be useful, but their value depends on the characteristic and release question. A document with no stated decision purpose is usually weak evidence.
The table is a planning comparison, not a universal PPAP element list. Customer-specific requirements, contract terms and part risk should decide which records are submitted, retained or omitted. For example, a cosmetic reference may matter more than an extended dimensional record for one part, while an assembly interface may deserve the reverse. Ask the supplier to show the connection between requirement, process step, measurement method and reaction; do not infer that a familiar document title proves that connection.
| Evidence area | Buyer decision supported | Useful content | Part-specific question |
|---|---|---|---|
| Design baseline | Which revision and characteristics are being approved? | Controlled drawing/CAD, marked features and applicable specifications. | Which interfaces, notes or cosmetic zones govern acceptance? |
| Process and control logic | How will relevant conditions be controlled after approval? | Process flow, control-plan logic, checks and stated reaction path. | Which process steps can affect the critical characteristics? |
| Measurement evidence | Does the produced part meet the agreed feature or functional decision? | Results tied to revision, feature ID, method, units and sample identity. | What datum, fixture, condition and uncertainty are appropriate? |
| Material and appearance evidence | Is the agreed input and visual condition represented? | Grade identity, agreed record type, colour or limit reference where needed. | Does resin, colour, texture or exposure create a special risk? |
| Submission decision record | What was accepted, rejected or conditionally released? | Part identifier, scope, open items, disposition and approving authority. | What remains blocked, by whom and until when? |
03
Make measurement and inspection evidence interpretable
An injection molding quality report should let a reviewer reconstruct what was measured and why it bears on acceptance. At minimum, agree the controlled revision, characteristic identifier, nominal and tolerance where applicable, actual result, units, method, sample or cavity identity when relevant, and any stated condition of measurement. Add the fixture or datum strategy for features whose result changes with support, orientation or clamping. A spreadsheet of numbers without these links may look complete but cannot reliably show whether the result relates to the released part definition.
Likewise, injection molding inspection is not a single universal activity. A flexible snap, a cosmetic surface and a tight assembly location may need different methods and decision conditions. NIST defines metrological traceability as a property of a measurement result linked to a reference through a documented, unbroken calibration chain, with each link contributing to uncertainty [4]. NIST also cautions that traceability by itself does not guarantee fitness for purpose [4]. Therefore, do not accept a calibration statement as a substitute for agreeing whether the method, fixture and measurement uncertainty are suitable for the specific feature.
04
Review samples as evidence, not as a silent specification
Physical samples are valuable because they expose assembly feel, appearance and handling conditions that may not be obvious in a drawing. Yet an approved sample should be labelled to its revision, material decision, tool or cavity context where relevant, and review purpose. Record whether it is a visual reference, an assembly sample, a dimensional sample or evidence from the intended production route. If a sample departs from the drawing but is accepted temporarily, write a deviation or concession record rather than allowing the part to redefine the requirement by habit.
Conduct the review with a short decision log in front of the cross-functional team. It should distinguish closed evidence from open actions: for example, a result awaiting a mating-part check, an appearance issue needing a limit reference, or a measurement that needs a revised fixture approach. Approval status should be explicit—accepted, conditionally accepted, rejected or awaiting information—and tied to authority. The right sample quantity, review method and approval condition are part-specific.
05
Keep the decision usable when the part changes
A PPAP package becomes stale when the baseline changes and the change is not connected to the original approval. Establish a simple change trigger list before release: drawing or CAD revision, resin grade or additive change, tool repair or modification that affects the part, cavity addition, process-route change, inspection-method change, appearance-reference change, or packing change that can affect the product. The list is not a claim that every event needs the same response. It is a prompt to decide whether notification, re-sampling, partial evidence or a new submission is needed for the particular agreement. AIAG’s APQP overview specifically includes change management and gated management among its updated subjects [2].
The final record should tell a future reviewer exactly what was approved: the baseline, evidence reviewed, status, open items, temporary conditions and next review trigger. Store it with the controlled purchase and technical records rather than relying on a mailbox thread. When an alternative material, repaired tool or revised measurement method is proposed later, compare it with that record and route it to the named approver. This does not promise that changes have no effect; it makes the effect assessment and buyer decision visible. A proportionate, traceable release record is the central deliverable of a well-planned submission.
Practical takeaway
Before you move
to the next review.
- State the release decision the submission must support, including any conditions that would block routine purchasing.
- Freeze and identify the applicable drawing/CAD revision, material direction, visual references, packaging requirements and relevant tooling context.
- Map every requested record to a buyer decision; identify which evidence is submitted, retained or not required for this part.
- Agree feature-specific measurement methods, fixturing or datums, result format and who judges exceptions before results are reviewed.
- Record the approval status, open actions, owners and change triggers in one controlled decision record.
FAQ
Common questions
Does every molded part need the same PPAP package?
No. AIAG describes PPAP as a process for demonstrating that design-record and specification requirements are consistently met in an actual production context [1], but the submission scope should be set by the customer requirements, contract and part-specific risk. Define the decision, the evidence needed for it and the records that may be retained before the supplier prepares the package.
Is a production sample automatically an approval sample?
No. A physical part can support dimensional, cosmetic, assembly or process evidence, but its purpose must be recorded. Identify the controlled revision, material and review purpose, then state whether the buyer accepted it, accepted it conditionally, rejected it or needs further evidence. A sample should not silently replace the drawing or documented acceptance criteria.
What should a buyer do when a result is outside the expected condition?
First confirm the controlled requirement, sample identity and measurement method. Then request a documented description of the result, potential affected scope, proposed containment and any decision needed from the product owner. The buyer should decide whether to accept a documented deviation, request further evidence or withhold release. The route and authority should be agreed in advance for the part.
References
Source material
- [1] Automotive Industry Action Group (AIAG), “Production Part Approval Process (PPAP).”
- [2] Automotive Industry Action Group (AIAG), “Advanced Product Quality Planning (APQP).”
- [3] Automotive Industry Action Group (AIAG), “Control Plan.”
- [4] National Institute of Standards and Technology (NIST), “Metrological Traceability.”
This guide is general information for early procurement and engineering discussion. It does not replace product-specific DFM, qualification, validation, regulatory assessment or legal advice.